Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05032755 · ClinicalTrials.gov registry record · NA

Low Nicotine Cigarettes, Smoking, and Chronic Pain

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT05032755: Completed NA study, sponsored by Duke University.

NCT05032755 is a NA study that has completed, run by Duke University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05032755, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effects of switching to very low nicotine content (VLNC) cigarettes versus normal nicotine content (NNC) cigarettes on experiences with craving, withdrawal, and pain among individuals with chronic back pain who smoke cigarettes daily.

Primary Outcome

Average number of cigarettes smoked per day over the past week, as reported on timeline follow-back interview at each weekly visit

Interventions

  • OTHER SPECTRUM NRC 102/103 investigational cigarettes
  • OTHER SPECTRUM NRC 600/601 investigational cigarettes

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-06-23
Est. Completion 2024-07-04
Phase NA
Duke University

1,725 total trials

What the finished NCT05032755 record still lists

NCT05032755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which SPECTRUM NRC 102/103 investigational cigarettes is the first listed.

NCT05032755 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05032755 about?

NCT05032755 is a clinical study titled "Low Nicotine Cigarettes, Smoking, and Chronic Pain". The purpose of this study is to evaluate the effects of switching to very low nicotine content (VLNC) cigarettes versus normal nicotine content (NNC) cigarettes on experiences with craving, withdrawal, and pain among individuals with chronic back pain who smoke cigarettes daily.

What is the current status of trial NCT05032755?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-23. Estimated completion is 2024-07-04.

What interventions are being tested in trial NCT05032755?

The interventions under investigation include: SPECTRUM NRC 102/103 investigational cigarettes (OTHER), SPECTRUM NRC 600/601 investigational cigarettes (OTHER).

Who is sponsoring clinical trial NCT05032755?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05032755's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05032755, the US trial registry maintained by the National Library of Medicine. NCT05032755 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.